Distinct MCM10 Proteasomal Degradation Profiles by Primate Lentiviruses Vpr Proteins.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
15 01 2020
Historique:
received: 11 11 2019
revised: 28 12 2019
accepted: 10 01 2020
entrez: 19 1 2020
pubmed: 19 1 2020
medline: 18 2 2021
Statut: epublish

Résumé

Viral protein R (Vpr) is an accessory protein found in various primate lentiviruses, including human immunodeficiency viruses type 1 and 2 (HIV-1 and HIV-2) as well as simian immunodeficiency viruses (SIVs). Vpr modulates many processes during viral lifecycle via interaction with several of cellular targets. Previous studies showed that HIV-1 Vpr strengthened degradation of Mini-chromosome Maintenance Protein10 (MCM10) by manipulating DCAF1-Cul4-E3 ligase in proteasome-dependent pathway. However, whether Vpr from other primate lentiviruses are also associated with MCM10 degradation and the ensuing impact remain unknown. Based on phylogenetic analyses, a panel of primate lentiviruses Vpr/x covering main virus lineages was prepared. Distinct MCM10 degradation profiles were mapped and HIV-1, SIVmus and SIVrcm Vprs induced MCM10 degradation in proteasome-dependent pathway. Colocalization and interaction between MCM10 with these Vprs were also observed. Moreover, MCM10 2-7 interaction region was identified as a determinant region susceptible to degradation. However, MCM10 degradation did not alleviate DNA damage response induced by these Vpr proteins. MCM10 degradation by HIV-1 Vpr proteins was correlated with G

Identifiants

pubmed: 31952107
pii: v12010098
doi: 10.3390/v12010098
pmc: PMC7019430
pii:
doi:

Substances chimiques

Gene Products, vpr 0
Proteasome Endopeptidase Complex EC 3.4.25.1
Minichromosome Maintenance Proteins EC 3.6.4.12

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Nature. 2014 Jan 9;505(7482):229-33
pubmed: 24402281
Mol Biol Cell. 2007 Oct;18(10):4085-95
pubmed: 17699597
J Virol. 1995 Feb;69(2):882-8
pubmed: 7815556
Proc Natl Acad Sci U S A. 2016 May 10;113(19):5311-6
pubmed: 27114546
J Virol. 2000 Aug;74(15):7039-47
pubmed: 10888643
J Biol Chem. 2015 Jul 10;290(28):17380-9
pubmed: 26032416
Microbes Infect. 2005 Jul;7(9-10):1150-60
pubmed: 15908254
Mol Biol Evol. 2016 Jul;33(7):1870-4
pubmed: 27004904
J Biol Chem. 2016 Feb 5;291(6):2696-711
pubmed: 26679995
Virology. 1996 Aug 15;222(2):391-400
pubmed: 8806523
Virology. 2000 Oct 10;276(1):16-26
pubmed: 11021990
Nature. 2005 May 19;435(7040):374-9
pubmed: 15902263
Cell. 2014 Jan 16;156(1-2):134-45
pubmed: 24412650
Nucleic Acids Res. 2012 Aug;40(15):7332-46
pubmed: 22570418
J Virol. 2015 Dec;89(23):12118-30
pubmed: 26401039
Cell Host Microbe. 2008 Jun 12;3(6):388-98
pubmed: 18541215
mBio. 2018 Oct 23;9(5):
pubmed: 30352932
Trends Microbiol. 2019 Aug;27(8):715-723
pubmed: 31085095
Virol J. 2010 Jun 07;7:119
pubmed: 20529298
PLoS Pathog. 2006 Dec;2(12):e127
pubmed: 17140287
Virology. 1995 Oct 1;212(2):331-9
pubmed: 7571402
Cytokine. 2010 Jul;51(1):1-9
pubmed: 20347598
Mol Cell. 2018 Jun 7;70(5):961-970.e5
pubmed: 29883611
J Biol Chem. 2017 Aug 4;292(31):13008-13021
pubmed: 28646110
J Virol. 1997 Jul;71(7):5579-92
pubmed: 9188632
J Virol. 2017 Apr 13;91(9):
pubmed: 28202763
J Biol Chem. 2017 Jun 30;292(26):10779-10790
pubmed: 28515316
Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):7311-5
pubmed: 8041786
J Mol Biol. 1999 Oct 22;293(2):321-31
pubmed: 10550212
Viruses. 2016 Jul 28;8(8):
pubmed: 27483302
J Mol Biol. 2016 Jul 3;428(13):2744-57
pubmed: 27181198
PLoS One. 2014 Jan 22;9(1):e86840
pubmed: 24466265
Trends Biochem Sci. 2012 Dec;37(12):509-16
pubmed: 22989858
Genes (Basel). 2017 Feb 17;8(2):
pubmed: 28218679
J Biol Chem. 2009 Sep 4;284(36):24662-72
pubmed: 19608746
J Virol. 1998 Apr;72(4):3037-44
pubmed: 9525626
Microbes Infect. 2007 Apr;9(4):490-7
pubmed: 17347016
Nat Struct Mol Biol. 2016 Oct;23(10):933-940
pubmed: 27571178
J Biol Chem. 2006 Jun 23;281(25):17259-65
pubmed: 16636053
J Virol. 2007 May;81(10):5284-93
pubmed: 17344301
mBio. 2016 Sep 13;7(5):
pubmed: 27624129
Retrovirology. 2007 Nov 26;4:84
pubmed: 18039376
EMBO J. 1994 Apr 1;13(7):1525-33
pubmed: 8156990
J Biol Chem. 2016 Aug 12;291(33):16936-16947
pubmed: 27354282
Semin Cell Dev Biol. 2014 Jun;30:121-30
pubmed: 24662891
Proc Natl Acad Sci U S A. 1998 Apr 28;95(9):5281-6
pubmed: 9560267
J Mol Biol. 2003 Mar 14;327(1):215-27
pubmed: 12614620
Virology. 1994 May 1;200(2):623-31
pubmed: 8178448

Auteurs

Hao Chang (H)

Viral Infectious Diseases Unit, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan.
Laboratory of Viral Infectious Diseases, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Science, The University of Tokyo, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan.
Photonics Control Technology Team, RIKEN Center for Advanced Photonics, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan.

Lowela Siarot (L)

Viral Infectious Diseases Unit, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan.

Ryosuke Matsuura (R)

Viral Infectious Diseases Unit, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan.
Laboratory of Viral Infectious Diseases, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Science, The University of Tokyo, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan.

Chieh-Wen Lo (CW)

Viral Infectious Diseases Unit, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan.
Photonics Control Technology Team, RIKEN Center for Advanced Photonics, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan.
Laboratory of Global Animal Resource Science, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan.

Hirotaka Sato (H)

Viral Infectious Diseases Unit, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan.
Nakamura Laboratory, Baton Zone program, Riken Cluster for Science, Technology and Innovation Hub, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan.

Hiroyuki Otsuki (H)

Viral Infectious Diseases Unit, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan.

Yoko Aida (Y)

Viral Infectious Diseases Unit, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan.
Laboratory of Viral Infectious Diseases, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Science, The University of Tokyo, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan.
Laboratory of Global Animal Resource Science, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan.
Nakamura Laboratory, Baton Zone program, Riken Cluster for Science, Technology and Innovation Hub, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH